Specialist R&D Tax & Grant Funding Advisors

Biomedical Catalyst 2019 round 1: early and late stage awards


The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):

    • disease prevention and proactive management of health and chronic conditions
    • earlier and better detection and diagnosis of disease, leading to better patient outcomes

  • tailored treatments that either change the underlying disease or offer potential cures

This competition closes at midday 12pm UK time on the deadline stated.

The Biomedical Catalyst has 4 funding strands to support the progression of projects from initial concept through to late stage development:

  1. Feasibility
  2. Primer
  3. Early stage
  4. Late stage

This competition combines the early and late stage strands.

A separate competition combining the feasibility and primer strands is being run in conjunction with this one. You can apply for this early and late stage competition without needing to go through feasibility and primer.

The aim of this competition is to enable companies to create a data package that can support the subsequent testing of your products or carry out evaluations in a clinical setting or another relevant environment. This can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • prototyping
  • product development planning
  • intellectual property protection
  • demonstrating of clinical utility and effectiveness
  • demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Your project must focus on the development of a product or process that is an innovative solution to a health and care challenge.

This competition has 2 stages.

Stage 1: assessed written application.

Stage 2: interview with our Major Awards Committee (MAC).

Be aware that your project may be subject to interim reviews at important decision points.

Project Dates:

  • Competition opens: Monday 21 January 2019
  • Registration closes: Wednesday 3 April 2019, 12:00pm

Who Can Apply:

State aid

Any UK business claiming funding must be eligible to receive state aid at the time Innovate UK confirm you will be awarded funding. If you are unsure please take legal advice. For further information see their general guidance.

Your project

Your project must start by 1 September 2019 and end by 31 March 2021. It can last between 3 and 18 months.

If your project’s total eligible costs or duration fall outside of Innovate UK's eligibility criteria, you must provide justification by email to support@innovateuk.ukri.org at least 10 days before the competition closes. They will decide whether to approve your request.

Lead applicant

To lead a project or work alone you must:

  • be a UK-registered micro, small or medium-sized enterprise (SME) or a research and technology organisation (RTO)
  • be an organisation focused on life science
  • carry out your project in the UK

You can work alone or in partnership with others (SMEs, academics or research organisations).

If your project is academic-led you need to apply to the Medical Research Council instead.

Your Proposal:

Support is available for any life science sector or discipline, including (but not limited to):

  • medical technologies and devices
  • stratified healthcare
  • advanced therapies (gene and cell therapies)
  • digital health
  • drug discovery
  • diagnostics

If you choose the innovation area ‘Diagnostics, medical technology and devices’, you must indicate in the initial project summary whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.

Research categories:

Innovate UK will fund feasibility studies and industrial research projects. Please see the general guidance to help you decide which category your project fits in.

Projects Innovate UK will not fund

Innovate UK will not fund projects as part of this competition that are in scope for the Biomedical Catalyst feasibility or primer awards.

Learn more about the feasibility or primer awards

Interested in applying? We can help.

  • Win Rate - Myriad Associates’ boast a 70% success rate with Innovate UK applications. 
  • Winning Application - We’ve had some of the highest scoring applications in Europe. In fact, we recently helped 4 Irish companies win a total of €14.9m in the Irish DTIF Grant Funding competition.
  • Honest & Trustworthy – We will not waste your time or money. If we feel your application won't succeed, we will tell you before we undertake the application process.
  • Risk-free Eligibility Call – Call us for a free eligibility call to see if you have an application worth applying for.

Click here to discuss your application with one of our expert grant bid writers or visit Innovate UK to find out more

Related articles